07/11/19 -"We have made some adjustments to take into account the huge impairment and added some first costs (€120m for 2019-21) in the implementation of the €300-350m cost reduction plan to our P&L. "
Pages
61
Language
English
Published on
07/11/19
You may also be interested by these reports :
12/03/26
The merger is largely integrated, with portfolio clean-up nearly complete. The focus now shifts to execution. At its Investor Day, DSM-Firmenich ...
12/03/26
Wacker’s earnings were largely expected following its detailed FY2025 preliminary release in January 2026. Investors reacted positively to the 2026 ...
04/03/26
Symrise reported a robust FY2025 performance and is strengthening its foundations as demand gradually normalises. Through the ONE SYM transformation ...
04/03/26
The Middle East conflict has driven oil and gas prices higher, pressuring chemical companies through elevated feedstock and energy costs. Upstream ...